Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
8.21
USD
|
+0.98%
|
|
+1.99%
|
-11.82%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
120.9
|
99.39
|
981.5
|
1,044
|
692.1
|
593.4
|
-
|
-
|
Enterprise Value (EV)
1 |
567.1
|
99.39
|
1,440
|
1,378
|
692.1
|
1,115
|
1,125
|
1,143
|
P/E ratio
|
-1.22
x
|
-0.96
x
|
-2.51
x
|
4.96
x
|
25.2
x
|
36.8
x
|
25.9
x
|
23.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.33
x
|
0.28
x
|
1.76
x
|
1.16
x
|
1.17
x
|
1.15
x
|
1.08
x
|
1.05
x
|
EV / Revenue
|
1.55
x
|
0.28
x
|
2.59
x
|
1.53
x
|
1.17
x
|
2.17
x
|
2.04
x
|
2.02
x
|
EV / EBITDA
|
8.18
x
|
1.52
x
|
7.54
x
|
3.32
x
|
5.22
x
|
8.71
x
|
7.9
x
|
7.74
x
|
EV / FCF
|
-16.7
x
|
-3.01
x
|
27.4
x
|
4.6
x
|
-
|
-121
x
|
38.1
x
|
17.9
x
|
FCF Yield
|
-5.98%
|
-33.2%
|
3.65%
|
21.8%
|
-
|
-0.82%
|
2.62%
|
5.6%
|
Price to Book
|
0.48
x
|
0.66
x
|
2.15
x
|
1.97
x
|
1.31
x
|
1.2
x
|
1.2
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
37,417
|
38,112
|
88,824
|
78,497
|
74,344
|
72,275
|
-
|
-
|
Reference price
2 |
3.231
|
2.608
|
11.05
|
13.30
|
9.310
|
8.210
|
8.210
|
8.210
|
Announcement Date
|
2/24/20
|
2/24/21
|
2/23/22
|
2/22/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
365.1
|
351.3
|
556.2
|
901.7
|
593.7
|
514.7
|
550.9
|
566.7
|
EBITDA
1 |
69.34
|
65.48
|
191
|
414.7
|
132.7
|
128
|
142.5
|
147.7
|
EBIT
1 |
-39.09
|
-15.54
|
101
|
308.4
|
51.78
|
56.44
|
66.13
|
59.88
|
Operating Margin
|
-10.71%
|
-4.42%
|
18.17%
|
34.2%
|
8.72%
|
10.97%
|
12%
|
10.57%
|
Earnings before Tax (EBT)
1 |
-84.34
|
-66.66
|
38.99
|
269.5
|
33.9
|
20.01
|
30.2
|
38.19
|
Net income
1 |
-96.44
|
-99.42
|
-220
|
230.3
|
27.92
|
16.31
|
23.85
|
32.52
|
Net margin
|
-26.42%
|
-28.3%
|
-39.55%
|
25.55%
|
4.7%
|
3.17%
|
4.33%
|
5.74%
|
EPS
2 |
-2.646
|
-2.715
|
-4.400
|
2.680
|
0.3700
|
0.2230
|
0.3164
|
0.3495
|
Free Cash Flow
1 |
-33.92
|
-32.98
|
52.5
|
299.8
|
-
|
-9.183
|
29.5
|
64
|
FCF margin
|
-9.29%
|
-9.39%
|
9.44%
|
33.25%
|
-
|
-1.78%
|
5.36%
|
11.29%
|
FCF Conversion (EBITDA)
|
-
|
-
|
27.48%
|
72.31%
|
-
|
-
|
20.71%
|
43.34%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
130.16%
|
-
|
-
|
123.67%
|
196.82%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/24/20
|
2/24/21
|
2/23/22
|
2/22/23
|
3/5/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
127.2
|
190.2
|
199
|
284.8
|
184.3
|
233.7
|
181
|
165.8
|
114.3
|
132.6
|
126.8
|
141.8
|
102.1
|
133.1
|
137.6
|
EBITDA
1 |
37.66
|
90.1
|
101.1
|
158.1
|
49.93
|
105.5
|
51.01
|
47.12
|
9.199
|
25.13
|
32.47
|
41.55
|
16.77
|
37.15
|
38.4
|
EBIT
1 |
5.373
|
69.69
|
79.97
|
132.7
|
13.07
|
82.68
|
30.54
|
27.5
|
-9.499
|
3.245
|
12.7
|
20.83
|
-1.833
|
18.89
|
18.98
|
Operating Margin
|
4.22%
|
36.63%
|
40.19%
|
46.58%
|
7.09%
|
35.39%
|
16.87%
|
16.58%
|
-8.31%
|
2.45%
|
10.01%
|
14.69%
|
-1.8%
|
14.19%
|
13.79%
|
Earnings before Tax (EBT)
1 |
-8.909
|
37.71
|
69.88
|
123.8
|
3.092
|
72.77
|
21.8
|
28.07
|
-12.98
|
-2.996
|
7.6
|
10.83
|
-12.1
|
10.95
|
10.55
|
Net income
1 |
-251.5
|
42.01
|
58.77
|
103.4
|
2.312
|
65.87
|
15.9
|
25.1
|
-7.726
|
-5.347
|
5.7
|
8.12
|
-9.1
|
8.2
|
7.9
|
Net margin
|
-197.72%
|
22.08%
|
29.53%
|
36.31%
|
1.25%
|
28.19%
|
8.79%
|
15.13%
|
-6.76%
|
-4.03%
|
4.49%
|
5.73%
|
-8.92%
|
6.16%
|
5.74%
|
EPS
2 |
-6.390
|
0.4700
|
0.6500
|
1.150
|
0.0300
|
0.8300
|
0.2100
|
0.3300
|
-0.1000
|
-0.0700
|
0.0434
|
0.1293
|
-0.1191
|
0.1271
|
0.1078
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/1/21
|
2/23/22
|
5/3/22
|
7/27/22
|
11/1/22
|
2/22/23
|
5/2/23
|
7/26/23
|
11/1/23
|
3/5/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
446
|
-
|
458
|
334
|
-
|
522
|
532
|
550
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.434
x
|
-
|
2.399
x
|
0.8057
x
|
-
|
4.078
x
|
3.733
x
|
3.725
x
|
Free Cash Flow
1 |
-33.9
|
-33
|
52.5
|
300
|
-
|
-9.18
|
29.5
|
64
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
54.5%
|
-
|
3.93%
|
4.3%
|
5.38%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
1.85%
|
2.07%
|
2.71%
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
880.1
|
1,154
|
1,200
|
Book Value Per Share
2 |
6.790
|
3.940
|
5.130
|
6.760
|
7.090
|
6.820
|
6.870
|
6.570
|
Cash Flow per Share
2 |
-
|
-
|
-
|
4.020
|
-
|
1.140
|
1.090
|
1.270
|
Capex
1 |
36.1
|
30.5
|
35.1
|
45.8
|
-
|
71.3
|
64.5
|
61.9
|
Capex / Sales
|
9.88%
|
8.67%
|
6.32%
|
5.08%
|
-
|
13.86%
|
11.71%
|
10.92%
|
Announcement Date
|
2/24/20
|
2/24/21
|
2/23/22
|
2/22/23
|
3/5/24
|
-
|
-
|
-
|
Last Close Price
8.21
USD Average target price
9.688
USD Spread / Average Target +18.00% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.82% | 593M | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B | | +3.85% | 8.11B |
Diversified Chemicals
|